News & Events

HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018

TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that its senior management team will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place in San Francisco, January 8-10, 2018.

full press release

Category: Press Releases
Topics: HTG
Posted on:

Return To List

Page last updated December 20, 2017